Sandra Levy
ARTICLES BY THIS AUTHOR
- 7/6/2021
Fresenius Kabi debuts smaller-dose fentanyl citrate injection
Fresenius Kabi’s fentanyl citrate injection, 50 mcg per ml, is the only 1-ml presentation available of the drug. - 7/5/2021
Alembic gets FDA blessing for generic Macrodantin
Nitrofurantoin capsules have a market value of roughly $23 million for the 12 months ended March 2021, according to IQVIA. - 7/5/2021
Schnucks names Ted Schnuck executive vice president of supermarkets
Dave Peacock, president and COO, will transition back to being a member of Schnucks' board of directors. - 7/5/2021
FDA tentatively OKs new dosage strength of Zydus’ generic Gilenya
Zydus Cadilla had previously received the agency's approval to market the generic in a 0.5 mg dosage strength. - 7/5/2021
Aurobindo Pharma continues injectable business restructuring
Aurobindo is consolidating all of its injectable business and related assets under its subsidiary Eugia Pharma. - 7/5/2021
Camber intros generic Klor-Con
Camber's potassium chloride extended-release tablets are used to prevent or treat low blood levels of potassium (hypokalemia). - 7/5/2021
Parata acquires Synergy Medical
Synergy Medical’s 150 employees will join Parata, with the SynMed business continuing to operate out of Quebec with Jean Boutin as president. - 7/1/2021
AAM reflects on anniversary of USMCA
In celebrating USMCA's one-year anniversary, the AAM said the trade deal has been a win for companies, health systems, patients and taxpayers. - 7/1/2021
Breckenridge signs multiproduct agreement with Welding
The agreement currently covers one delayed-release tablet product and two injectable products, which collectively had sales of $300 million for the year ended April 2021. - 6/29/2021
Boehringer Ingelheim gets green light for new Pradaxa indications
Pradaxa now is the first FDA-approved oral blood-thinning medication for children.
